Differential sensitivity of three sublines of the rat Dunning prostate tumor system R3327 to radiation and/or local tumor hyperthermia. 1998

P Peschke, and E W Hahn, and F Wenz, and F Lohr, and F Braunschweig, and G Wolber, and I Zuna, and M Wannenmacher
Department of Radiation Oncology, German Cancer Research Center, Heidelberg.

To better understand the relationship of the growth characteristics of tumor tissues and their response to ionizing radiation alone and in combination with local tumor hyperthermia, we compared three different tumor sublines of the Dunning rat prostate carcinoma R3327. This report includes results obtained with the anaplastic AT1 subline (volume doubling time 5.2 days), the moderately differentiated mucin-secreting HI subline (volume doubling time about 9 days) and the well-differentiated, hormone-dependent H subline (volume doubling time about 17 days). The effects of single doses of photons (10 to 40 Gy) with and without local tumor hyperthermia (35 min immersion at 43.5 degrees C) were quantified by growth delay. The time to reach five times the volume at the time of treatment after 30 Gy alone was found to be 56.0, 134.9 and 184.0 days for the R3327-AT1, HI and H tumors, respectively. The R3327-H tumor was more radiosensitive than the AT1 or HI subline. Five of nine R3327-H tumors were controlled locally with a single dose of photons (40 Gy). Local tumor hyperthermia alone induced growth delay in both differentiated tumors, while the anaplastic tumor subline did not respond. Combined treatment modalities with heat applied directly after irradiation revealed isoeffective thermal enhancement ratios for 30 Gy which decreased from 1.59 for the AT1 tumor and 1.42 for the HI tumor to 1.23 in the well-differentiated subline R3327-H.

UI MeSH Term Description Entries
D006979 Hyperthermia, Induced Abnormally high temperature intentionally induced in living things regionally or whole body. It is most often induced by radiation (heat waves, infra-red), ultrasound, or drugs. Fever Therapy,Hyperthermia, Local,Hyperthermia, Therapeutic,Thermotherapy,Induced Hyperthermia,Therapeutic Hyperthermia,Therapy, Fever,Local Hyperthermia
D008297 Male Males
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D011836 Radiation Tolerance The ability of some cells or tissues to survive lethal doses of IONIZING RADIATION. Tolerance depends on the species, cell type, and physical and chemical variables, including RADIATION-PROTECTIVE AGENTS and RADIATION-SENSITIZING AGENTS. Radiation Sensitivity,Radiosensitivity,Sensitivity, Radiation,Tolerance, Radiation,Radiation Sensitivities,Radiation Tolerances,Radiosensitivities,Sensitivities, Radiation,Tolerances, Radiation
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

P Peschke, and E W Hahn, and F Wenz, and F Lohr, and F Braunschweig, and G Wolber, and I Zuna, and M Wannenmacher
October 1984, The Journal of urology,
P Peschke, and E W Hahn, and F Wenz, and F Lohr, and F Braunschweig, and G Wolber, and I Zuna, and M Wannenmacher
June 1985, The Journal of urology,
P Peschke, and E W Hahn, and F Wenz, and F Lohr, and F Braunschweig, and G Wolber, and I Zuna, and M Wannenmacher
July 2002, International journal of radiation oncology, biology, physics,
P Peschke, and E W Hahn, and F Wenz, and F Lohr, and F Braunschweig, and G Wolber, and I Zuna, and M Wannenmacher
January 1987, Journal of pineal research,
P Peschke, and E W Hahn, and F Wenz, and F Lohr, and F Braunschweig, and G Wolber, and I Zuna, and M Wannenmacher
March 2007, International journal of radiation oncology, biology, physics,
P Peschke, and E W Hahn, and F Wenz, and F Lohr, and F Braunschweig, and G Wolber, and I Zuna, and M Wannenmacher
May 2003, Radiation research,
P Peschke, and E W Hahn, and F Wenz, and F Lohr, and F Braunschweig, and G Wolber, and I Zuna, and M Wannenmacher
August 2005, The Prostate,
P Peschke, and E W Hahn, and F Wenz, and F Lohr, and F Braunschweig, and G Wolber, and I Zuna, and M Wannenmacher
July 1997, The Prostate,
P Peschke, and E W Hahn, and F Wenz, and F Lohr, and F Braunschweig, and G Wolber, and I Zuna, and M Wannenmacher
January 1988, The Prostate,
P Peschke, and E W Hahn, and F Wenz, and F Lohr, and F Braunschweig, and G Wolber, and I Zuna, and M Wannenmacher
January 1991, The Prostate,
Copied contents to your clipboard!